期刊文献+

2007-2010年医院鲍曼不动杆菌感染的耐药分析 被引量:5

Antimicrobial resistance analyses of Acintobacter baumannii isolated in hospital from 2007 to 2010
原文传递
导出
摘要 目的了解医院鲍曼不动杆菌感染的分布及耐药情况。方法分析鲍曼不动杆菌菌株的标本来源和临床分布情况,用最低抑菌浓度(minimal inhibitory concentration,MIC)法结合纸片扩散法(K—B法)检测其对抗菌药物的敏感性。结果2007--2010年共分离鲍曼不动杆菌62株,其中53株(占85.5%)分离自痰标本,21株(占33.9%)分离自重症监护室(intensive care units,ICU)。62例患者中54.8%(34例)的患者患有严重的肺部感染疾病。分离菌对头孢哌酮/舒巴坦的耐药率为20.0%、敏感率为73.3%,对其他抗菌药物的耐药率超过60.0%。泛耐药菌占33.9%(21株),其中52.4%(11株)的泛耐药鲍曼不动杆菌感染发生在ICU病房。结论鲍曼不动杆菌的耐药率较高,且呈多重耐药趋势。加强菌株的耐药性监测,以药敏结果指导临床用药有助于减少耐药菌株的出现。 Objective To investigate the prevalence and antimicrobial resistance of Acinetobacter baumannii in nosocomial infection. Methods Clinical features and the origin of A. baumannii samples were analyzed retrospectively. The minimal inhibitory concentration (MIC) and Kriby-Bauer diffusion test (K-B) were used to determine the susceptibility to the antimicrobial agents. Results A total of 62 strains of A. bauman- nii were isolated from 2007 to 2010. Fifty-three strains( 85.5% ) of specimens were separated from respiratory tract. The isolation rate ofA. baumannii was the highest in intensive care units (ICU) (21 strains, 33.9% ). 54.8% (34/62) of patients suffered from severe lung infection. The resistance rate of cefoperazon/sulbactam was 20.0%, and the susceptible rate was 73.3%. The resistance rate to other antimicrobial agents is above 60.0%. The prevalence of muhi-drug resistance of A. baumannii was about 33.9%, and 52.4% of this kind of A. baumannii were occured in ICU. Conclusion The infection of A. baumannii is more and more severe and tends to be resistant to multiple-drug and pan-drugs. The susceptible testing should be conducted to help the clinic to decrease the resistance rate.
出处 《国际医学寄生虫病杂志》 CAS 2011年第3期183-185,共3页 International JOurnal of Medical Parasitic Diseases
关键词 鲍曼不动杆菌 感染 耐药性 Acinetobacter baumannii Infection Drug resistance
  • 相关文献

参考文献7

二级参考文献31

共引文献135

同被引文献27

  • 1朱旭慧,孙自镛,简翠,李丽,张蓓,申正义.不动杆菌属的耐药性分析[J].中国抗感染化疗杂志,2005,5(6):342-345. 被引量:37
  • 2中华人民共和国卫生部医政司.全国检验操作规程[M].3版.南京:东南大学出版社,2006:743.
  • 3Giamarellou H,Poulakou G.Multidrug-resistant gram-negative in- fections:what are the treatment options. Drugs [J], 2009, 69(14):1879- 1901.
  • 4Munoz-Price LS,Weinstein RA.Acinetobacter infection[J].NEngl J Med,2008,358(12):1271-1281.
  • 5Giamarellou H,Poulakou G.Multidrug-resistant gram-negative infections[J]:what are the treatment options. Drugs, 2009, 69(14): 1879- 1901.
  • 6姚火春.微生物实验指导[M]1.第2版.北京:中国农业出版社,2002.
  • 7Lee-Jene Teng, Po-Ren Hsueh, Yu-Hsuan Huang. Identification of Bacteroides thetaiotaomicron on the Basis of an Unexpected Specific Amplicon of Universal 16S Ribosomal DNA PCR[J]. Journal of Clinical Microbiology, 2004,42(4): 1727-1729.
  • 8Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibili- ty testing: Twenty- first information supplement[S]. [MIO0 - S21]. 2011.
  • 9汪艳,董志扬,梁磊,等.重症监护病房病原菌分布及耐药性分析[J].中华感染医学杂志,2010,20(4):562-563.
  • 10莫美娟,周蕾,潘艳艳.重症监护病房铜绿假单胞菌的耐药性分析[J].中华感染医学杂志,2010,20(6):873-874.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部